BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Northwest Biotherapeutics, Inc. 

21720 23rd Drive SE, Suite 100

Bothell  Washington  98021  U.S.A.
Phone: 425-608-3000-or-877-606-9246-Toll-Free Fax: 425-608-3026


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Services


Collaborations

Cytogen Corporation  Development of ex vivo prostate cancer immunotherapy





 Company News
Northwest Biotherapeutics (NWBO) Featured In Presentations At The AACR Annual Meeting 4/21/2015 1:17:27 PM
Northwest Biotherapeutics (NWBO) Included In New Index Of The "Top 25 Cancer Immunotherapy Companies" 4/16/2015 10:37:18 AM
Northwest Biotherapeutics (NWBO) Included In New Index Of The "Top 25 Cancer Immunotherapy Companies" 4/16/2015 8:21:17 AM
Northwest Biotherapeutics (NWBO) To Present At World Vaccine Congress 2015 4/9/2015 8:08:22 AM
Northwest Biotherapeutics (NWBO) Announces $40 Million Financing 4/2/2015 10:18:10 AM
Northwest Biotherapeutics (NWBO) Reports Promising Survival Data In 51 Gbm Patients Treated With Dcvax-L 3/27/2015 7:24:57 AM
Northwest Biotherapeutics (NWBO) To Present At The 2nd Immunotherapy Of Cancer Conference, ITOC-2 3/24/2015 11:22:04 AM
Northwest Biotherapeutics (NWBO)'s Phase 3 Trial Of Dcvax-L For Gbm Brain Cancer Approved To Proceed In Canada And Under Way At Two Sites 2/19/2015 11:07:29 AM
Northwest Biotherapeutics (NWBO) To Present At 17th Annual BIO CEO & Investor Conference 2/9/2015 11:25:31 AM
Northwest Biotherapeutics (NWBO) To Present At The 7th Annual Phacilitate Immunotherapy Forum 1/23/2015 10:38:39 AM
12345678910...